The Massachusetts company saw its fifth year of double-digit growth, with revenue projections set to top $150 million in 2023.

MariMed anticipates Betty’s Eddies will be available to Maine’s residents and seasonal adult-use customers in the coming months.

MariMed will bring its full product portfolio of award-winning and top-selling brands, genetics and products to one of the top cannabis markets in the United States.

Offering Betty’s Eddies in a single-serve package will provide a low-cost, convenient option to drive trial of the brand among new customers.